Product Information
TRESIBA 100 UNIT/ML VIAL is a brand product labeled by Novo Nordisk, priced at $9.0208 per ML under NDC 00169266211. Its NADAC has been published 366 times since Aug 21, 2019.
Strength
100 U/mL
Manufacturer
Novo NordiskNDC
00169266211
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
INSULIN DEGLUDECApproval Type
Biologic (BLA)
FDA Application
BLA203314On Market Since
11/21/2018
Pharmacological Classes
Price Statistics
The NADAC for TRESIBA 100 UNIT/ML VIAL has been published 366 times since Aug 21, 2019, and over the history we have for it it has declined 72.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.0208 per ML |
|---|---|
| All-time high | $32.6531 (Aug 16, 2023) |
| All-time low | $9.0208 (Aug 19, 2026) |
| 52-week high | $32.4900 |
| 52-week low | $9.0208 |
| Median price | $32.5200 |
| Average price | $30.4694 |
| Largest weekly change | -72.2% (Jan 14, 2026) |
| Weeks tracked | 366 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRESIBA 100 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for TRESIBA 100 UNIT/ML VIAL, manufactured by Novo Nordisk, is $9.0208 per ML (NDC 00169266211), effective Aug 19, 2026.
How has the price of TRESIBA 100 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for TRESIBA 100 UNIT/ML VIAL has declined 72.3%. It has been tracked across 366 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for TRESIBA 100 UNIT/ML VIAL?
Since Aug 21, 2019, the NADAC for TRESIBA 100 UNIT/ML VIAL has ranged from a low of $9.0208 (Aug 19, 2026) to a high of $32.6531 (Aug 16, 2023), with a median of $32.5200 per ML.
Are there cheaper alternatives to TRESIBA 100 UNIT/ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRESIBA 100 UNIT/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures TRESIBA 100 UNIT/ML VIAL?
TRESIBA 100 UNIT/ML VIAL (NDC 00169266211) is labeled by Novo Nordisk, and CMS classifies it as a brand product.